{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:50:49Z","timestamp":1792900249504,"version":"4.5.0"},"reference-count":59,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2007,5,29]],"date-time":"2007-05-29T00:00:00Z","timestamp":1180396800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:sec id=\"S0033291707000797_sec_a001\"><jats:title>Background<\/jats:title><jats:p>The impact of co-morbid substance use in first-episode schizophrenia has not been fully explored.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291707000797_sec_a002\"><jats:title>Method<\/jats:title><jats:p>This naturalistic follow-up of a cohort of 152 people with first-episode schizophrenia examined substance use and clinical outcome in terms of symptoms and social and neuropsychological function.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291707000797_sec_a003\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Data were collected on 85 (56%) of the patient cohort after a median period of 14 months. Over the follow-up period, the proportion of smokers rose from 60% at baseline to 64%. While 30% reported lifetime problem drinking of alcohol at baseline, only 15% had problem drinking at follow-up. Furthermore, while at baseline 63% reported lifetime cannabis use and 32% were currently using the drug, by the follow-up assessment the latter figure had fallen to 18.5%. At follow-up, persistent substance users had significantly more severe positive and depressive symptoms and greater overall severity of illness. A report of no lifetime substance use at baseline was associated with greater improvement in spatial working memory (SWM) at follow-up.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291707000797_sec_a004\" sec-type=\"conclusion\"><jats:title>Conclusions<\/jats:title><jats:p>Past substance use may impede recovery of SWM performance in people with schizophrenia in the year or so following first presentation to psychiatric services. The prevalence of substance use other than tobacco tends to diminish over this period, in the absence of specific interventions. Persistent substance use in first-episode schizophrenia is associated with more severe positive and depressive symptoms but not negative symptoms, and should be a target for specific treatment intervention.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0033291707000797","type":"journal-article","created":{"date-parts":[[2007,5,29]],"date-time":"2007-05-29T09:46:53Z","timestamp":1180432013000},"page":"79-88","source":"Crossref","is-referenced-by-count":73,"title":["Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study"],"prefix":"10.1017","volume":"38","author":[{"given":"I.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.\u00a0M.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.\u00a0H.","family":"Mutsatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.\u00a0B.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Huddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kapasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.\u00a0R.\u00a0E.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2007,5,29]]},"reference":[{"key":"S0033291707000797_ref038","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"S0033291707000797_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2003.08.001"},{"key":"S0033291707000797_ref001","doi-asserted-by":"publisher","DOI":"10.1037\/h0095049"},{"key":"S0033291707000797_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(02)00816-X"},{"key":"S0033291707000797_ref009","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.157.6.853"},{"key":"S0033291707000797_ref047","first-page":"399","article-title":"Computerised assessment in neuropsychiatry using CANTAB","volume":"85","author":"Sahakian","year":"1992","journal-title":"Journal of the Royal Society of Medicine"},{"key":"S0033291707000797_ref059","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1281-1"},{"key":"S0033291707000797_ref012","doi-asserted-by":"publisher","DOI":"10.1007\/s004060050064"},{"key":"S0033291707000797_ref026","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291797006041"},{"key":"S0033291707000797_ref005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1978.tb02357.x"},{"key":"S0033291707000797_ref032","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.157.4.558"},{"key":"S0033291707000797_ref008","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S0033291701003828","article-title":"Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or \u2018ecstasy\u2019: evidence for cognitive impairment","volume":"31","author":"Battachary","year":"2001","journal-title":"Psychological Medicine"},{"key":"S0033291707000797_ref006","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.4.486"},{"key":"S0033291707000797_ref057","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.183.4.304"},{"key":"S0033291707000797_ref029","first-page":"A63","article-title":"Treatment effects of conventional and atypical antipsychotics on cognition following a first episode of schizophrenia","volume":"18","author":"Kapasi","year":"2004","journal-title":"Journal of Psychopharmacology"},{"key":"S0033291707000797_ref041","volume-title":"The Revised National Adult Reading Test (NART)\u00a0\u2013\u00a0Test Manual","author":"Nelson","year":"1991"},{"key":"S0033291707000797_ref037","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.06.040"},{"key":"S0033291707000797_ref054","first-page":"133","article-title":"Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects","volume":"18","author":"Sorbara","year":"2003","journal-title":"Schizophrenia Research"},{"key":"S0033291707000797_ref019","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.6.509"},{"key":"S0033291707000797_ref050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"S0033291707000797_ref002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09925.x"},{"key":"S0033291707000797_ref036","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(88)90004-4"},{"key":"S0033291707000797_ref013","doi-asserted-by":"publisher","DOI":"10.1192\/pb.25.1.17"},{"key":"S0033291707000797_ref030","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(03)00130-0"},{"key":"S0033291707000797_ref039","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100907"},{"key":"S0033291707000797_ref014","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000591"},{"key":"S0033291707000797_ref022","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2004.09.013"},{"key":"S0033291707000797_ref024","first-page":"76","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"S0033291707000797_ref016","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-47148-5_12"},{"key":"S0033291707000797_ref044","doi-asserted-by":"publisher","DOI":"10.1016\/j.bandc.2005.04.002"},{"key":"S0033291707000797_ref034","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2005.02.017"},{"key":"S0033291707000797_ref040","doi-asserted-by":"publisher","DOI":"10.1046\/j.0001-690X.2003.00193.x"},{"key":"S0033291707000797_ref051","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00452.x"},{"key":"S0033291707000797_ref018","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.5.630"},{"key":"S0033291707000797_ref021","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.6.719"},{"key":"S0033291707000797_ref025","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00261-4"},{"key":"S0033291707000797_ref048","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(00)00063-3"},{"key":"S0033291707000797_ref033","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950040017002"},{"key":"S0033291707000797_ref046","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000467"},{"key":"S0033291707000797_ref045","first-page":"121","article-title":"Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses","volume":"18","author":"Potvin","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"key":"S0033291707000797_ref049","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(99)00070-1"},{"key":"S0033291707000797_ref035","doi-asserted-by":"publisher","DOI":"10.3109\/10826089609063969"},{"key":"S0033291707000797_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00249-3"},{"key":"S0033291707000797_ref058","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.1.127"},{"key":"S0033291707000797_ref028","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.181.43.s38"},{"key":"S0033291707000797_ref053","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700710"},{"key":"S0033291707000797_ref056","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.09.010"},{"key":"S0033291707000797_ref017","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033464"},{"key":"S0033291707000797_ref043","first-page":"48","article-title":"Substance use and cognition in early psychosis","volume":"28","author":"Pencer","year":"2003","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"S0033291707000797_ref052","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"S0033291707000797_ref003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02197.x"},{"key":"S0033291707000797_ref007","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.104.007237"},{"key":"S0033291707000797_ref027","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00387-0"},{"key":"S0033291707000797_ref031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2005.00554.x"},{"key":"S0033291707000797_ref015","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.156.6.798"},{"key":"S0033291707000797_ref020","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830110089011"},{"key":"S0033291707000797_ref004","first-page":"73","volume-title":"Schizophrenia: Positive and Negative Symptoms and Syndromes. Modern Problems in Pharmacopsychiatry","author":"Andreasen","year":"1990"},{"key":"S0033291707000797_ref055","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a006934"},{"key":"S0033291707000797_ref042","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00097-X"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291707000797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:22:28Z","timestamp":1556738548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291707000797\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,29]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0033291707000797"],"URL":"https:\/\/doi.org\/10.1017\/s0033291707000797","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,29]]}}}